Home
Sessions
PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
Safety and Feasibility of Hypofractionated Radiation Therapy for Relapsed/Refractory Lymphoma: Extended Follow-Up of a Phase I Trial

Sep 28

PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology

2763 - Safety and Feasibility of Hypofractionated Radiation Therapy for Relapsed/Refractory Lymphoma: Extended Follow-Up of a Phase I Trial

03:00pm - 04:00pm ET

Presenter(s)

Farris Jaamour, MD, MPH - University of Chicago Medicine, Chicago, IL